Parallax Volatility Advisers, L.P. - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 117 filers reported holding TG THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.

Quarter-by-quarter ownership
Parallax Volatility Advisers, L.P. ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$149,644
-94.5%
17,900
-83.7%
0.00%
-100.0%
Q2 2023$2,727,507
+5248.1%
109,803
+804.1%
0.01%
Q2 2022$51,000
-89.4%
12,145
-76.1%
0.00%
Q1 2022$483,000
-67.2%
50,839
-34.4%
0.00%
-100.0%
Q4 2021$1,473,000
-87.4%
77,513
-78.0%
0.00%
-88.9%
Q3 2021$11,727,000
+6.8%
352,388
+24.5%
0.01%
-10.0%
Q2 2021$10,982,000
+134.1%
283,100
+190.9%
0.01%
+150.0%
Q1 2021$4,692,000
+727.5%
97,331
+90.4%
0.00%
+300.0%
Q4 2019$567,000
+101.8%
51,107
+2.2%
0.00%
Q3 2019$281,000
-35.1%
50,0000.0%0.00%
Q2 2019$433,000
-16.9%
50,000
-22.8%
0.00%
Q1 2019$521,000
-40.9%
64,800
-58.9%
0.00%
-100.0%
Q3 2018$882,000
-10.5%
157,486
+110.0%
0.00%0.0%
Q2 2018$986,000
+1516.4%
75,000
+914.6%
0.00%
Q4 2017$61,000
-85.7%
7,392
-85.2%
0.00%
Q1 2016$426,000
-19.2%
50,000
+13.1%
0.00%
-100.0%
Q4 2015$527,00044,1970.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
M28 Capital Management LP 726,200$3,086,0003.46%
Paradigm Biocapital Advisors LP 1,964,709$8,350,0001.66%
683 Capital Management, LLC 3,300,000$14,025,0000.99%
MAVERICK CAPITAL LTD 6,747,549$28,677,0000.71%
Antara Capital LP 1,500,000$6,375,0000.27%
Parkwood LLC 47,168$1,375,0000.24%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,677,500$11,379,0000.24%
PURA VIDA INVESTMENTS, LLC 950,813$4,041,0000.24%
OCCUDO QUANTITATIVE STRATEGIES LP 567,576$2,412,0000.20%
Antara Capital LP 900,000$3,825,0000.16%
View complete list of TG THERAPEUTICS INC shareholders